BPIFA2 antibody (AA 151-249) (Cy5)
Quick Overview for BPIFA2 antibody (AA 151-249) (Cy5) (ABIN2171175)
Target
See all BPIFA2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 151-249
-
Predicted Reactivity
- Human
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human C20orf70
-
Isotype
- IgG
-
-
-
-
Application Notes
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- BPIFA2 (BPI Fold Containing Family A, Member 2 (BPIFA2))
-
Alternative Name
- C20orf70
-
Background
-
Synonyms: bA49G10.1, chromosome 20 open reading frame 70, lung and nasal epithelium carcinoma-associated protein 2, Neonatal submandibular gland protein, Parotid secretory protein, PSP, Short palate, short palate lung and nasal epithelium carcinoma associated 2, short palate, lung and nasal epithelium carcinoma associated protein 2, SPLC2_HUMAN, SPLUNC2.
Background: C20orf70
Target
-